Article

A Double-blind Randomized Comparative Clinical Trial to Evaluate the Safety and Efficacy of Dendritic Cell Vaccine Loaded with WT1 Peptides (TLP0-001) in Combination with S-1 in Patients with Advanced Pancreatic Cancer Refractory to Standard Chemotherapy

2019-02-25

Abstract excerpt

<title>Abstract</title> <p>Background: Pancreatic cancer is a refractory malignancy and the development of a new effective treatment strategy is needed. We generated a dendritic cell vaccine by culturing monocytes obtained by apheresis of blood from each patient, inducing their differentiation into dendritic cells, and pulsing with tumor antigen peptides. However, the clinical efficacy of the vaccine has not been...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6e602c5d-b87d-57bc-84f4-fe53e94da9a9
DOI: 10.21203/rs.2.148/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Double-blind Randomized Comparative Clinical Trial to Evaluate the Safety and Efficacy of Dendritic Cell Vaccine Loaded with WT1 Peptides (TLP0-001) in Combination with S-1 in Patients with Advanced Pancreatic Cancer Refractory to Standard ChemotherapyDOI 10.21203/rs.2.148/v2Read

A Peptide-Based Neoantigen Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard TreatmentSemantic proximity Read

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.Semantic proximity Read

A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer.Semantic proximity Read

Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?Semantic proximity Read

Generation of multiple peptide cocktail-pulsed dendritic cells as a cancer vaccine.Semantic proximity Read

Oxidative Stress-Induced Immunogenic Cell Death Enhances Whole-Cell Vaccine Efficacy in a Syngeneic Pancreatic Cancer ModelSemantic proximity Read

Human dendritic cells transfected with amplified MUC1 mRNA stimulate cytotoxic T lymphocyte responses against pancreatic cancer in vitro.Semantic proximity Read

First Reported Advanced Pancreatic Cancer With Hyperprogression Treated With PD-1 Blockade combined with chemotherapy: A Case Report And Literature ReviewSemantic proximity Read

Development of Cell Technologies Based on Dendritic Cells for Immunotherapy of Oncological DiseasesSemantic proximity Read

Tumoricidal activity of human dendritic cells.Semantic proximity Read

Dendritic cell vaccination in combination with erlotinib in a patient with inoperable lung adenocarcinoma: a case report.Semantic proximity Read

Glycyrrhiza uralensis polysaccharides as a DC-based Vaccine Adjuvant: Enhanced Immunotherapy Combined with PD-1 BlockadeSemantic proximity Read